Records containing: Pancreatic Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-09-12ClinicalTrials.gov study NCT03008304
-
CLINICAL_TRIALS study record update · 2019-08-28ClinicalTrials.gov study NCT00414570
-
CLINICAL_TRIALS study record update · 2019-08-22A Pilot Trial of PEGPH20 (Pegylated Hyaluronidase) in Combination With Avelumab (Anti-PD-L1 MSB0010718C) in Chemotherapy Resistant Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2019-08-08Prospective Analysis of Robot-Assisted Surgery
-
CLINICAL_TRIALS study record update · 2019-08-05Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-07-30Phase I Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)
-
CLINICAL_TRIALS study record update · 2019-07-25Adjuvant Gemcitabine Versus NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer: a Randomized Multicenter Phase III Study (NEOPAC Study)
-
CLINICAL_TRIALS study record update · 2019-07-19A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
-
CLINICAL_TRIALS study record update · 2019-07-18Official Title: A Phase 1B/2 Study of the Safety and Tolerability of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-07-16A Feasibility Study Assessing the Ability of an Ex-vivo Assay to Measure AMD3100's Ability to Overcome Tumour Immune-privilege and Bring T-lymphocytes Into Contact With Neoplastic Targets.
-
CLINICAL_TRIALS study record update · 2019-07-10A Pilot Study to Test the Feasibility of the Combination of Gemcitabine and Anti-PD1 Monoclonal Antibody (CT-011) in the Treatment of Resected Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2019-07-09EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI - The EXLIPSE Study
-
CLINICAL_TRIALS study record update · 2019-07-08Phase II Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas
-
CLINICAL_TRIALS study record update · 2019-07-02Validation of Circulating Biomarkers Using the Immunological Multiparameter Chip Technology (IMPACT) on Plasma Specimens Collected on CALGB 80303
-
CLINICAL_TRIALS study record update · 2019-06-19Prospective Phase I Study of Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2019-06-14POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection. a Nationwide Stepped-Wedge Cluster Randomized Trial
-
CLINICAL_TRIALS study record update · 2019-06-14Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage
-
CLINICAL_TRIALS study record update · 2019-06-12Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer: A Pilot Study
-
CLINICAL_TRIALS study record update · 2019-06-11Phase IB/II Trial of High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have No Prior Therapy for Their Metastatic Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2019-06-05A Randomized Three-arm Neoadjuvant and Adjuvant Feasibility and Toxicity Study of a GM-CSF Secreting Allogeneic Pancreatic Cancer Vaccine Administered Either Alone or in Combination With Either a Single Intravenous Dose or Daily Metronomic Oral Doses of Cyclophosphamide for the Treatment of Patients With Surgically Resected Adenocarcinoma of the Pancreas
-
CLINICAL_TRIALS study record update · 2019-05-30Phase IB/II Trial of High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have No Prior Therapy for Their Metastatic Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2019-05-15Gemcitabine Plus Capecitabine Versus Gemcitabine Alone In Advanced Pancreatic Cancer. A Randomized Phase III Trial
-
CLINICAL_TRIALS study record update · 2019-05-13The Diagnostic Yield of Malignancy Comparing Cytology, FISH and Molecular Analysis of Cell Free Cytology Brush Supernatant in Patients With Biliary Strictures Undergoing Endoscopic Retrograde Cholangiography (ERC): A Prospective Study
-
CLINICAL_TRIALS study record update · 2019-05-09EUS-guided Celiac Plexus Neurolysis Using Ropivacaine Combined With Anhydrous Alcohol for the Treatment of Abdominal Pain in Pancreatic Cancer: a Prospective Multicenter Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2019-05-08Clinical Research of ROBO1 Specific BiCAR-NK Cells on Patients With Pancreatic Cancer